"bureaucracy & Beliefs": Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine

Drugs: Education, Prevention and Policy

Volumn 22, Issue 3, 2015, Pages 255-262

  Bojko, Martha J ^a   Mazhnaya, Alyona ^b   Makarenko, Iuliia ^c   Marcus, Ruthanne ^a   Dvoriak, Sergii ^c   Islam, Zahedul ^b   Altice, Frederick L ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ICF INTERNATIONAL   (United States)

^c UKRAINIAN INSTITUTE ON PUBLIC HEALTH POLICY   (Ukraine)

^d YALE UNIVERSITY   (United States)

Author keywords

Health beliefs; methadone; opioid substitution therapy; people who inject drugs; qualitative research; substance abuse; treatment barriers; Ukraine

Indexed keywords

EID: 84938840000     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687637.2015.1016397     Document Type: Article

References (60)

1. Alistar, S. S., Owens, D. K., & Brandeau, M. L. (2011). Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine. PLoS Medicine, 8, e1000423
2. Altice, F. L., Bruce, R. D., Lucas, G. M., Lum, P. J., Korthuis, P. T., Flanigan, T. P. BHIVES Collaborative. (2011). HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndrome, 56, S22-S32
3. Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376, 367-387
4. Alves, P., & Winstock, A. (2011). Patients' knowledge about treatment for opiate dependence. The Psychiatric Bulletin, 35, 448-453
5. Bachireddy, C., Soule, M. C., Izenberg, J. M., Dvoryak, S., Dumchev, K., & Altice, F. L. (2014). Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug and Alcohol Dependence, 134, 106-114
6. Balakiryeva, O. M., Bondar, T. V., Sereda, Y. V., & Sazonova, Y. O. (2012). Analytical report. Kyiv, Ukraine: ICF International HIV/AIDS Alliance in Ukraine
7. Basu, S., Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2006). Models for integrating buprenorphine therapy into the primary HIV care setting. Clinical Infectious Diseases, 42, 716-721
8. Bojko, M. J., Dvoriak, S., & Altice, F. L. (2013). At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine. [Editorial]. Addiction, 108, 1697-1699
9. Brewin, C. R., & Bradley, C. (1989). Patient preferences and randomised clinical trials. British Medical Journal, 299, 313-315
10. Brislin, R. W. (1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychcology, 1, 185-216
11. Bruce, R. D., Dvoryak, S., Sylla, L., & Altice, F. L. (2007). HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine-Programme description and policy implications. International Journal of Drug Policy, 18, 326-328
12. Burruano, L., & Kruglov, Y. (2009). HIV/AIDS epidemic in Eastern Europe: Recent developments in the Russian Federation and Ukraine among women. Gender Medicine, 6, 277-289
13. Coulter, A., & Ellins, J. (2007). Effectiveness of strategies for informing, educating, and involving patients. British Medical Journal, 335, 24-27
14. De Maeyer, J., van Nieuwenhuizen, C., Bongers, I. L., Broekaert, E., & Vanderplasschen, W. (2013). Profiles of quality of life in opiatedependent individuals after starting methadone treatment: A latent class analysis. International Journal of Drug Policy, 24, 342-350
15. Degenhardt, L., Mathers, B. M., Wirtz, A. L., Wolfe, D., Kamarulzaman, A., Carrieri, M. P. Beyrer, C. (2014). What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. International Journal of Drug Policy, 25, 53-60
16. Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D. Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. The Lancet, 382, 1564-1574
17. Dennis, B. B., Naji, L., Bawor, M., Bonner, A., Varenbut, M., Daiter, J. Thabane, L. (2014). The effectiveness of opioid substitution treatments for patients with opioid dependence: A systematic review and multiple treatment comparison protocol. Systematic Reviews, 3, 105
18. Dutta, A., Wirtz, A., Stanciole, A., Oelrichs, R., Semini, I., Baral, S. Cleghorn, F. (2013). The global HIV epidemics among people who inject drugs. Washington, DC: World Bank
19. Fingleton, N., Matheson, C., & Jaffray, M. (2015). Changes in mental health during opiate replacement therapy: A systematic review. Drugs: Education, Prevention & Policy, 22, 1-18
20. Glaser, B., & Strauss, A. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine De Gruyther
21. Gordon, R., McDermott, L., Stead, M., & Angus, K. (2006). The effectiveness of social marketing interventions for health improvement: What's the evidence? Journal of the Royal Institute of Public Health, 120, 1133-1139
22. Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Review, 2, CD004145
23. Holt, E. (2014). Fears over future of opioid substitution therapy in Crimea. The Lancet, 383, 1113
24. Izenberg, J. M., & Altice, F. L. (2010). Next steps for Ukraine-Abolition of HIV registries, Implementation of routine HIV testing and expansion of services. Addiction, 105, 569-570
25. Izenberg, J. M., Bachireddy, C., Soule, M., Kiriazova, T., Dvoryak, S., & Altice, F. L. (2013). High rates of police detention among recently released HIV-infected prisoners in Ukraine: Implications for health outcomes. Drug and Alcohol Dependence, 133, 154-160
26. Kazatchkine, M. (2014). Russia's ban on methadone for drug users in Crimea will worsen the HIV/AIDS epidemic and risk public health. British Medical Journal, 348, g3118
27. Kerr, T., Wodak, A., Elliott, R., Montaner, J. S., & Wood, E. (2004). Opioid substitution and HIV/AIDS treatment and prevention. The Lancet, 364, 1918-1919
28. King, M., Nazareth, I., Lampe, F., Bower, P., Chandler, M., Morou, M. Lai, R. (2005). Impact of participant and physician intervention preferences on randomized trials: A systematic review. JAMA, 293, 1089-1099
29. Korthuis, P. T., Tozzi, M. J., Nandi, V., Fiellin, D. A., Weiss, L., Egan, J. E. BHIVES Collaborative. (2011). Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. Journal of Acquired Immune Deficiency Syndrome, 56, S39-45
30. Kotler, P., Roberto, N., & Lee, N. (2002). Social marketing: Improving the quality of life. New York, NY: Sage
31. Krahn, M., & Naglie, G. (2008). The next step in guideline development: Incorporating patient preferences. JAMA, 300, 436-438
32. Lawrinson, P., Ali, R., Buavirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B. Zhou, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103, 1484-1492
33. Lin, C., Wu, Z., & Detels, R. (2011). Opiate users' perceived barriers against attending methadone maintenance therapy: A qualitative study in China. Substance Use & Misuse, 46, 1190-1198
34. Lincoln, Y., & Guba, E. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage Publications, Inc
35. Liu, Y., Li, L., Zhang, Y., Zhang, L., Shen, W., Xu, H. Zhou, W. (2013). Assessment of attitudes towards methadone maintenance treatment between heroin users at a compulsory detoxification centre and methadone maintenance clinic in Ningbo, China. Substance Abuse Treatment, Prevention, and Policy, 8, 29
36. Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretro-viral therapy among HIV-infected drug users: A meta-analysis. AIDS & Behavior, 14, 731-747
37. Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A. Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372, 1733-1745
38. McCarty, D., Gustafson, D. H., Wisdom, J. P., Ford, J., Choi, D., Molfenter, T. Cotter, F. (2007). The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence, 88, 138-145
39. McPherson, K., Britton, A. R., & Wennberg, J. E. (1997). Are randomized controlled trials controlled? Patient preferences and unblind trials. Journal of Royal Society of Medicine, 90, 652-656
40. Michels, I. I., Stover, H., & Gerlach, R. (2007). Substitution treatment for opioid addicts in Germany. Harm Reduction Journal, 4, 5
41. Mimiaga, M. J., Safren, S. A., Dvoryak, S., Reisner, S. L., Needle, R., & Woody, G. (2010). ''We fear the police, and the police fear us'': Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care, 22, 1305-1313
42. Mondloch, M. V., Cole, D. C., & Frank, J. W. (2001). Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes. CMAJ, 165, 174-179
43. Nieburg, P., & Carty, L. (2012). Injection drug use in Ukraine: The challenges of providing HIV prevention and care. Washington, DC: Center for Strategic and International Studies (CSIS)
44. Nosyk, B., Guh, D. P., Sun, H., Oviedo-Joekes, E., Brissette, S., Marsh, D. C. Anis, A. H. (2011). Health related quality of life trajectories of patients in opioid substitution treatment. Drug & Alcohol Dependence, 118, 259-264
45. Notley, C., Blyth, A., Maskrey, V., Craig, J., & Holland, R. (2013). The experience of long-term opiate maintenance treatment and reported barriers to recovery: A qualitative systematic review. European Addiction Research, 19, 287-298
46. Notley, C., Maskrey, V., & Holland, R. (2012). The needs of problematic drug misusers not in structured treatment-A qualitative study of perceived treatment barriers and recommendations for services. Drugs: Education, Prevention & Policy, 19, 40-48
47. O'Connor, A. M., Bennett, C. L., Stacey, D., Barry, M., Col, N. F., Eden, K. B. Thomson R. (2009). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Review, 3, CD001431
48. Padon, A. A., & Baren, J. M. (2011). Achieving a decision-making triad in adolescent sexual health care. [Review]. Adolescent Medicine: State of the Art Reviews, 22, 183-194, vii
49. Schaub, M., Chtenguelov, V., Subata, E., Weiler, G., & Uchtenhagen, A. (2010). Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. International Journal of Drug Policy, 21, 229-233
50. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed. ). Thousand Oaks, CA: Sage
51. Sylla, L., Bruce, R. D., Kamarulzaman, A., & Altice, F. L. (2007). Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy, 18, 306-312
52. Taylor, S., & Bogdan, R. (1985). Introduction to qualitative research methods: The search for meanings. New York, NY: Wiley
53. Uhlmann, S., Milloy, M. J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D. Woods, E. (2010). Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 105, 907-913
54. Ukrainian Ministry of Health. (2013). Zahal'noderzhavna tsilova socialna programa protydiji VIL-infekciji/SNIDu na 2014-2018 (Ukraine National HIV/AIDS Program for 2014-2018). Kyiv, Ukraine: Ukraine Ministry of Health
55. UNAIDS. (2013). Global report: UNAIDS report on the global AIDS epidemic 2013. Joint United Nations Programme on HIV/AIDS
56. UNAIDS. (2014). The Gap Report. Joint United Nations Programme on HIV/AIDS
57. VERBI Software-Consult-Sozialforschung GmbH. (1989-2014). MAXQDA, Berlin, Germany.
58. Vickerman, P., Platt, L., Jolley, E., Rhodes, T., Kazatchkine, M. D., & Latypov, A. (2014). Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: Insights from modelling. International Journal of Drug Policy, 25, 1163-1173
59. Weiss, L., Netherland, J., Egan, J. E., Flanigan, T. P., Fiellin, D. A., Finkelstein, R. BHIVES Collaborative. (2011). Integration of buprenorphine/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative. Journal of Acquired Immune Deficiency Syndrome, 56, S68-S75
60. Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355-366